Mindstate Design Labs
PrivateLast Round
Seed
Feb 10, 2022
Total Funding Raised
$11.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mindstate Design Labs operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Seed round in February 2022.
Mindstate Design Labs is a biotechnology company that utilizes an AI-powered platform, Osmanthus, for the precision design of novel psychedelic-inspired therapeutics for mental health disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mindstate Design Labs Comparables
Compare Mindstate Design Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CaaMTech | 86% | |
| Tactogen | 86% | |
| Freedom Biosciences | 81% |
For institutional investors. Book with your work email.
Mindstate Design Labs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mindstate Design Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Masnavi Capital | Seed |
| Ayuh Ventures | Seed |
| Harvard Management Company | Seed |
| Metaplanet Holdings | Seed |
| Gaingels | Seed |
| Lionheart Ventures | Seed |
| K50 Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 46% MoM.
- May 15, 2026
Monthly visitors increased 286% MoM, reaching 7.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Mindstate Design Labs, Inc is developing a chemical formulation of 5-MeO-MiPT for several neuropsychiatric disorders.
For institutional investors. Book with your work email.
Mindstate Design Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mindstate Design Labs's valuation, stock price, and market status.
Is Mindstate Design Labs a public or private company?
Mindstate Design Labs is a private company.
What is the current stock price of Mindstate Design Labs?
Mindstate Design Labs is a private company, so its shares have no public market price. Caplight tracks Mindstate Design Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mindstate Design Labs worth (valuation)?
Valuation information for Mindstate Design Labs is not publicly available.
Can I buy Mindstate Design Labs stock?
Mindstate Design Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mindstate Design Labs's last funding round?
Mindstate Design Labs's most recent funding round was Seed on February 10, 2022.
Who are the main investors in Mindstate Design Labs?
Key investors in Mindstate Design Labs include Masnavi Capital, Initialized Capital Management.
Will Mindstate Design Labs IPO soon?
No public IPO plans have been announced for Mindstate Design Labs.
How can I track Mindstate Design Labs secondary market activity?
Caplight tracks bids, offers, and trades in Mindstate Design Labs's shares on secondary markets.